The International Space Station is not the only orbiting platform for experiments. Varda Space Industries has its own orbiting facility, or at least it had one in orbit for 10 months until it returned to Earth in February (shown below). And now the company has another $90 million in funding to continue to develop its capsules.
Varda, founded in 2020, represents the next phase of the space industry, where lower cost launches allow companies to be creative with their own spacecraft. In this case, biopharma is being asked to consider the advantages of a launches that remove gravity from the equation:
While gravitational forces do not directly impact thermodynamic properties of systems, they do significantly impact kinetic and hydrodynamic processes. Microgravity suppresses convection and sedimentation, resulting in more uniform supersaturation, as well as diffusion-driven transport. The resulting environment enables crystallization outcomes that lead to improvements in bioavailability, enhanced physicochemical properties, differentiated intellectual property, and new routes of administration — all realized by conducting research in microgravity.
While Varda is taking advantage of the lower launch costs made available by reusable rockets, it too wants to have reusable capsules down the line to reduce costs even further. Of course, it is not as glamorous as a permanently manned space station, but these crewless capsules should be sufficient for the needs of many if not most companies.
Note: Varda is also the name of a dwarf planet, which took its name from JRR Tolkien’s Middle Earth.
Our Awesome Universe 